Contact allergens and sodium lauryl sulphate upregulate vascular endothelial growth factor in normal keratinocytes

British Journal of Dermatology

Volumn 137, Issue 4, 1997, Pages 540-544

  Palacio, S ^a   Schmitt, D ^a   Viac, J ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DODECYL SULFATE SODIUM; VASCULOTROPIN;

ANTIGEN RECOGNITION; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTACT DERMATITIS; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; SKIN ALLERGY; VASCULAR ENDOTHELIUM;

ALLERGENS; CELL CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENDOTHELIAL GROWTH FACTORS; HUMANS; HYDROCORTISONE; KERATINOCYTES; LYMPHOKINES; METALS; SODIUM DODECYL SULFATE; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030731587     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03783.x     Document Type: Article

References (23)

1. Dvorak HF, Brown LF, Detmar M, Dvorak A. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995; 146: 1029-39.
2. Ballaun C, Weninger W, Uthman A et al. Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 1995; 104: 7-10.
3. Detmar M, Brown L, Claffey K et al. Overexpression of vascular permeability factor and its receptors in psoriasis. J Exp Med 1994; 180: 1141-6.
4. Brown LF, Olbricht SM, Berse B et al. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 1995; 154: 2801-7.
5. Brown LF, Harrist TJ, Yeo KT et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis and erythema multiforme. J Invest Dermatol 1995; 104: 744-9.
6. Brown LF, Yeo KT, Berse B et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176: 1375-9.
7. Frank S, Hübner G, Breier G et al. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 1995; 270: 12607-13.
8. Lee SW, Morhenn VB, Ilnicka M et al. Autocrine stimulation of interleukin 1α and transforming growth factor α production in human keratinocytes and its antagonism by glucocorticoids. J Invest Dermatol 1991; 97: 106-10.
9. Guin JD, Wallis MS, Walls R et al. Quantitative vasoconstrictor assay for topical corticosteroids: the puzzling case of fluocinolone acetonide. J Am Acad Dermatol 1993; 29: 197-202.
10. Li Q, Aoyama K. Study of dose-response relationship in contact sensitivity using an in vitro assay. Contact Dermatitis 1992; 27: 16-21.
11. Minchenko A, Bauer T, Salceda S, Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 1994; 71: 374-9.
12. Guéniche A, Viac J, Lizard G, et al. Effect of nickel on the activation state of normal human keratinocytes through interleukin 1 and intercellular adhesion molecule 1 expression. Br J Dermatol 1994; 131: 250-6.
13. Guéniche A, Viac J, Lizard G et al. Effect of various metals on intercellular adhesion molecule-1 expression and tumour necrosis factor alpha production by normal human keratinocytes. Arch Dermatol Res 1994; 286: 466-70.
14. Guéniche A, Viac J, Lizard G et al. Effect of different sensitizing haptens on intercellular adhesion molecule-1 expression and cytokine production by normal human keratinocytes. Eur J Dermatol 1995; 5: 320-5.
15. Viac J, Palacio S, Schmitt D, Claudy A. Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes. Arch Dermatol Res 1997; 289: 158-63.
16. Goldberg MA, Schneider TJ. Similarities between the oxygen-sensing mechanism regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 1994; 269: 4355-9.
17. Lisby S, Müller KM, Jongeneel V et al. Nickel and skin irritants up-regulate tumor necrosis factor-α mRNA in keratinocytes by different but potentially synergistic mechanisms. Int Immunol 1995; 7: 343-52.
18. Hansen J, Möllgaard B. Biotransformation of contact allergens in the skin. In: Immunological and Pharmacological Aspects of Atopic and Contact Eczema (Czernielewski JM, ed.). Basel: Karger, 1991; 89-93.
19. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 1996; 271: 21793-7.
20. Claffey KP, Wilkinson WO, Spiegelman BM. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem 1992; 267: 16317-22.
21. Yang-Yen HF, Chambard JC, Sun YL et al. Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990; 62: 1205-15.
22. Tischer E, Mitchell R, Hartman T et al. The human gene for vascular endothelial growth factor. J Biol Chem 1991; 266: 11947-54.
23. Clauss M, Gerlach M, Gerlach H et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172: 1535-45.